{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T04:53:19Z","timestamp":1794113599070,"version":"4.8.0"},"reference-count":25,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Allogenic hematopoietic cell transplantation (alloHCT) is a well-established curative modality for acute lymphoblastic leukemia (ALL), yet large amounts of data describing alloHCT outcomes in Philadelphia (Ph)-like ALL are lacking. We retrospectively analyzed archived DNA samples from consecutive adults with B-cell Ph-negative ALL who underwent alloHCT in complete remission (CR) (n = 127) at our center between 2006 and 2020. Identification of fusions associated with Ph-like ALL was performed using cumulative results from RNA-seq, conventional cytogenetics, fluorescence in situ hybridization, and whole genome array studies. Fusions associated with Ph-like ALL were detected in 56 (44%) patients, of whom 38 were carrying CRLF2r. Compared with other non\u2013Ph-like ALL (n = 71), patients with fusions associated with Ph-like ALL were more frequently Hispanic (P = .008), were less likely to carry high-risk cytogenetics (P &amp;lt; .001), and were more likely to receive blinatumomab prior to HCT (P = .019). With the median followup of 3.5 years, patients with Ph-like ALL fusions had comparable posttransplant outcomes compared with other B-cell ALL: 3-year relapse-free survival (RFS) (41% vs 44%; P = .36), overall survival (OS) (51% vs 50%; P = .59), and relapse (37% vs 31%; P = .47). In multivariable analysis, age (P = .023), disease status at the time of transplant (P &amp;lt; .001), and donor type (P = .015) influenced OS. RFS (primary endpoint) was significantly influenced by disease status (P &amp;lt; .001) and conditioning regimen intensity (P = .014). In conclusion, our data suggest that alloHCT consolidation results in similarly favorable survival outcomes in adult patients with Ph-like fusions and other high-risk B-cell ALL.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022007597","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T19:16:43Z","timestamp":1657567003000},"page":"4936-4948","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":30,"title":["Outcomes of allogeneic hematopoietic cell transplantation in adults with fusions associated with Ph-like ALL"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9564-4498","authenticated-orcid":false,"given":"Ibrahim","family":"Aldoss","sequence":"first","affiliation":[{"name":"1Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0736-4977","authenticated-orcid":false,"given":"Dongyun","family":"Yang","sequence":"additional","affiliation":[{"name":"2Department of Computational and Quantitative Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanina","family":"Tomasian","sequence":"additional","affiliation":[{"name":"3Department of Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Mokhtari","sequence":"additional","affiliation":[{"name":"4Department of Clinical and Translational Project Development, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Jackson","sequence":"additional","affiliation":[{"name":"3Department of Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1581-1327","authenticated-orcid":false,"given":"Zhaohui","family":"Gu","sequence":"additional","affiliation":[{"name":"2Department of Computational and Quantitative Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milhan","family":"Telatar","sequence":"additional","affiliation":[{"name":"3Department of Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hooi","family":"Yew","sequence":"additional","affiliation":[{"name":"3Department of Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8226-471X","authenticated-orcid":false,"given":"Monzr M.","family":"Al Malki","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandeep","family":"Salhotra","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Khaled","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9728-7292","authenticated-orcid":false,"given":"Haris","family":"Ali","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Aribi","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karamjeet S.","family":"Sandhu","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Mei","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shukaib","family":"Arslan","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3830-5320","authenticated-orcid":false,"given":"Paul","family":"Koller","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0803-9607","authenticated-orcid":false,"given":"Andrew","family":"Artz","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Aoun","sequence":"additional","affiliation":[{"name":"3Department of Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqing","family":"Gu","sequence":"additional","affiliation":[{"name":"3Department of Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Snyder","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forrest M.","family":"Stewart","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Curtin","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony S.","family":"Stein","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raju","family":"Pillai","sequence":"additional","affiliation":[{"name":"3Department of Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Marcucci","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Forman","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Pullarkat","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9082-0680","authenticated-orcid":false,"given":"Ryotaro","family":"Nakamura","sequence":"additional","affiliation":[{"name":"1Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Afkhami","sequence":"additional","affiliation":[{"name":"3Department of Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"issue":"11","key":"2022082615225457200_B1","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N Engl J Med."},{"issue":"4","key":"2022082615225457200_B2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.2016.69.0073","article-title":"High frequency and poor outcome of Philadelphia chromosome-like acute lymphoblastic leukemia in adults","volume":"35","author":"Roberts","year":"2017","journal-title":"J Clin Oncol."},{"issue":"5","key":"2022082615225457200_B3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood-2016-07-726588","article-title":"Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults","volume":"129","author":"Jain","year":"2017","journal-title":"Blood."},{"issue":"23","key":"2022082615225457200_B4","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMc1412123","article-title":"Ph-like acute lymphoblastic leukemia in older adults","volume":"371","author":"Herold","year":"2014","journal-title":"N Engl J Med."},{"issue":"26","key":"2022082615225457200_B5","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1182\/blood-2009-09-245944","article-title":"Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic\/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia","volume":"115","author":"Harvey","year":"2010","journal-title":"Blood."},{"issue":"12","key":"2022082615225457200_B6","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/ng.2803","article-title":"Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse","volume":"45","author":"Perez-Andreu","year":"2013","journal-title":"Nat Genet."},{"issue":"7","key":"2022082615225457200_B7","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood-2009-05-218560","article-title":"Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia","volume":"115","author":"Kang","year":"2010","journal-title":"Blood."},{"issue":"4","key":"2022082615225457200_B8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/leu.2016.375","article-title":"High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL","volume":"31","author":"Tasian","year":"2017","journal-title":"Leukemia."},{"issue":"25","key":"2022082615225457200_B9","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1182\/blood-2016-12-758979","article-title":"Targetable kinase gene fusions in high-risk B-ALL: a study from the Children\u2019s Oncology Group","volume":"129","author":"Reshmi","year":"2017","journal-title":"Blood."},{"key":"2022082615225457200_B10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yamp.2019.07.004","article-title":"Philadelphia-like lymphoblastic leukemia: approach to testing in clinical laboratories for diagnosis","volume":"2","author":"Afkhami","year":"2019","journal-title":"Adv Mol Pathol."},{"issue":"33","key":"2022082615225457200_B11","doi-asserted-by":"crossref","first-page":"22872","DOI":"10.18632\/oncotarget.25089","article-title":"SRC\/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia","volume":"9","author":"Sarno","year":"2018","journal-title":"Oncotarget."},{"issue":"2","key":"2022082615225457200_B12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1182\/blood-2016-05-707653","article-title":"Potent efficacy of combined PI3K\/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia","volume":"129","author":"Tasian","year":"2017","journal-title":"Blood."},{"issue":"17","key":"2022082615225457200_B13","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1182\/blood-2012-03-415448","article-title":"Targeting JAK1\/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia","volume":"120","author":"Maude","year":"2012","journal-title":"Blood."},{"issue":"6","key":"2022082615225457200_B14","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1182\/blood-2008-07-168625","article-title":"Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison","volume":"113","author":"Cornelissen","year":"2009","journal-title":"Blood."},{"issue":"7","key":"2022082615225457200_B15","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.bbmt.2016.03.025","article-title":"Cytogenetics does not impact outcomes in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation","volume":"22","author":"Aldoss","year":"2016","journal-title":"Biol Blood Marrow Transplant."},{"issue":"8","key":"2022082615225457200_B16","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/s41409-021-01253-6","article-title":"Non-inferior long-term outcomes of adults with Philadelphia chromosome-like acute lymphoblastic leukemia","volume":"56","author":"Cho","year":"2021","journal-title":"Bone Marrow Transplant."},{"issue":"7","key":"2022082615225457200_B17","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1038\/s41409-021-01262-5","article-title":"Outcomes in patients with CRLF2 overexpressed acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation","volume":"56","author":"Koller","year":"2021","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"2022082615225457200_B18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn."},{"issue":"2","key":"2022082615225457200_B19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1182\/blood-2009-07-232124","article-title":"A population-based cytogenetic study of adults with acute lymphoblastic leukemia","volume":"115","author":"Moorman","year":"2010","journal-title":"Blood."},{"issue":"4","key":"2022082615225457200_B20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/blood.2020006287","article-title":"Tumor-intrinsic and-extrinsic determinants of response to blinatumomab in adults with B-ALL","volume":"137","author":"Zhao","year":"2021","journal-title":"Blood"},{"key":"2022082615225457200_B21","doi-asserted-by":"crossref","first-page":"106579","DOI":"10.1016\/j.leukres.2021.106579","article-title":"Efficacy of blinatumomab for MRD relapse in ALL post allogenic HCT","volume":"104","author":"Ali","year":"2021","journal-title":"Leuk Res."},{"issue":"12","key":"2022082615225457200_B22","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1182\/blood.2021013290","article-title":"Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia","volume":"139","author":"Gaballa","year":"2022","journal-title":"Blood."},{"issue":"11","key":"2022082615225457200_B23","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1080\/10428194.2019.1605510","article-title":"Response to single agent dasatinib post allogeneic transplant in B-cell acute lymphoblastic leukemia with NUP214-ABL1.","volume":"60","author":"Aldoss","year":"2019","journal-title":"Leuk Lymphoma."},{"issue":"19","key":"2022082615225457200_B24","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1182\/blood-2015-03-634006","article-title":"Rising rates of acute lymphoblastic leukemia in Hispanic children: trends in incidence from 1992 to 2011","volume":"125","author":"Barrington-Trimis","year":"2015","journal-title":"Blood."},{"issue":"9","key":"2022082615225457200_B25","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1182\/blood-2011-09-377713","article-title":"Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies","volume":"120","author":"G\u00f6kbuget","year":"2012","journal-title":"Blood."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/17\/4936\/1916907\/advancesadv2022007597.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/17\/4936\/1916907\/advancesadv2022007597.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T15:29:13Z","timestamp":1661527753000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/17\/4936\/485833\/Outcomes-of-allogeneic-hematopoietic-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":25,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2022,9,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022007597","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]}}}